Salvage helical tomotherapy for prostate cancer recurrence following definitive external beam radiotherapy: A case report

Lee,Sang  Hyub; Jung,Jinhong; Chang,Sung‑Goo

doi:10.3892/ol.2015.3346

Salvage helical tomotherapy for prostate cancer recurrence following definitive external beam radiotherapy: A case report

Authors:
- Sang Hyub Lee
- Jinhong Jung
- Sung‑Goo Chang
View Affiliations

Affiliations: Department of Urology, Kyung Hee University School of Medicine, Seoul 130‑872, Republic of Korea, Department of Radiation Oncology, Kyung Hee University School of Medicine, Seoul 130‑872, Republic of Korea
Published online on: June 9, 2015 https://doi.org/10.3892/ol.2015.3346
Pages: 1044-1046

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Salvage prostatectomy for recurrent prostate cancer after external beam radiotherapy (EBRT) has resulted in positive outcomes; however, it is technically challenging and is associated with a number of risks. When a patient exhibits recurrent prostate cancer following definitive EBRT and presents with comorbidities meaning that they cannot receive a prostatectomy, it is difficult to treat due to the numerous limitations of current salvage therapies. In the present study, two cases of salvage reirradiation using helical tomotherapy for locally recurrent prostate cancer following definitive EBRT are presented. The two patients received EBRT without severe complications. Local recurrence was confirmed by serum levels of prostate‑specific antigen, repeat prostate biopsy, prostate magnetic resonance imaging and a bone scan. Salvage reirradiation using helical tomotherapy was performed and resulted in promising outcomes without any complications. In conclusion, helical tomotherapy can be a safe and effective salvage treatment modality for locally recurrent prostate cancer following definitive EBRT.

View Figures

View References

1	Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, et al: Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. BJU Int. 109:22–29. 2012. View Article : Google Scholar : PubMed/NCBI
2	Roach M III, Bae K, Speight J, Wolkov HB, Rubin P, Lee RJ, Lawton C, Valicenti R, Grignon D and Pilepich MV: Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610. J Clin Oncol. 26:585–591. 2008. View Article : Google Scholar : PubMed/NCBI
3	Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, et al: Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet. 360:103–106. 2002. View Article : Google Scholar : PubMed/NCBI
4	Horwitz EM, Bae K, Hanks GE, Porter A, Grignon DJ, Brereton HD, Venkatesan V, Lawton CA, Rosenthal SA, Sandler HM, et al: Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. J Clin Oncol. 26:2497–2504. 2008. View Article : Google Scholar : PubMed/NCBI
5	Pilepich MV, Winter K, Lawton CA, Krisch RE, Wolkov HB, Movsas B, Hug EB, Asbell SO and Grignon D: Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys. 61:1285–1290. 2005. View Article : Google Scholar : PubMed/NCBI
6	Denham JW, Steigler A, Lamb DS, Joseph D, Turner S, Matthews J, Atkinson C, North J, Christie D, Spry NA, et al: Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. Lancet Oncol. 12:451–459. 2011. View Article : Google Scholar : PubMed/NCBI
7	D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A and Kantoff PW: 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial. JAMA. 292:821–827. 2004. View Article : Google Scholar : PubMed/NCBI
8	Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F and Mottet N: European Association of Urology: EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing and castration-resistant prostate cancer. Eur Urol. 65:467–479. 2014. View Article : Google Scholar : PubMed/NCBI
9	Kishi K, Sato M, Shirai S, Sonomura T and Yamama R: Reirradiation of prostate cancer with rectum preservation: Eradicative high-dose-rate brachytherapy with natural type hyaluronate injection. Brachytherapy. 11:144–148. 2012. View Article : Google Scholar : PubMed/NCBI
10	Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A and Amols HI: Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 70:1124–1129. 2008. View Article : Google Scholar : PubMed/NCBI
11	Vavassori A, Jereczek-Fossa BA, Beltramo G, De Cicco L, Fariselli L, Bianchi LC, Possanzini M, Bergantin A, DeCobelli O and Orecchia R: Image-guided robotic radiosurgery as salvage therapy for locally recurrent prostate cancer after external beam irradiation: Retrospective feasibility study on six cases. Tumori. 96:71–75. 2010.PubMed/NCBI
12	Shimbo M, Inoue K, Koike Y, Katano S and Kawashima K: Salvage I seed implantation for prostate cancer with postradiation local recurrence. Urol Int. 90:294–300. 2013. View Article : Google Scholar : PubMed/NCBI
13	Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M III and Shinohara K: Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int. 104:600–604. 2009. View Article : Google Scholar : PubMed/NCBI
14	Budäus L, Bolla M, Bossi A, Cozzarini C, Crook J, Widmark A and Wiegel T: Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature. Eur Urol. 61:112–127. 2012. View Article : Google Scholar : PubMed/NCBI
15	Ramey SJ and Marshall DT: Re-irradiation for salvage of prostate cancer failures after primary radiotherapy. World J Urol. 31:1339–1345. 2013. View Article : Google Scholar : PubMed/NCBI
16	Kong M, Hong SE and Chang SG: Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity. Onco Targets Ther. 7:553–566. 2014. View Article : Google Scholar : PubMed/NCBI